Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery

Sheikh Zayed Medical College

Status and phase: Not yet enrolling; Early Phase 1

Conditions: Hemodynamic Stability

Treatments: Drug: Lignocaine

Study type: Interventional

Funder types: Other

Identifiers

NCT05298761

ASarwar

Details and patient eligibility

About

Comparison of I/V nalbuphine versus I/V xylocain in attanuation of pressor response during intubation and laryngeoscopy in patients undergoing for thyroid surgery,selection of better supressor agent minimises the drug repated side effects like hypertention tachycardia but also helps in heamodynamically stability at induction.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• middle age(18_40)
• Asa 1 and 2
• Non hypertensive
• Thyroid patients
• patient who gives consent

Exclusion criteria

• hypertensive
• Asa 3 and 4
• Patient refusal

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Lignocain

Experimental group

Description:

I/V lignocain 1.5mg per kg given to participants in state dose

Treatment:

Drug: Lignocaine

nalbuphine

Experimental group

Description:

I/v nalbuphine 0.1mg per kg given to participants in stat dose

Treatment:

Drug: Lignocaine